Passage Bio, Inc. (PASG)

4.75 -0.29 (-5.75%) USD  |  NASDAQ  |  Sep 18, 16:00
4.70 -0.05 (-1.05%) After-Hours: 20:00
More

Passage Bio Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 10, 2026 --
June 26, 2026 --
June 10, 2026 --
May 12, 2026 --
May 06, 2026 --
April 24, 2026 --
April 21, 2026 --
April 20, 2026 --
March 30, 2026 --
March 04, 2026 --
March 03, 2026 --
February 10, 2026 --
December 31, 2025 --
November 24, 2025 --
November 18, 2025 --
November 12, 2025 --
Date Value
November 11, 2025 --
October 08, 2025 --
August 13, 2025 --
June 24, 2025 --
June 23, 2025 --
May 19, 2025 --
May 15, 2025 --
May 14, 2025 --
May 13, 2025 --
March 04, 2025 --
December 03, 2024 --
August 08, 2024 --
August 01, 2024 --
July 08, 2024 --
May 14, 2024 --
March 04, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade